Filing Flows › Evolent Health (EVH) › Guidance history
Evolent Health (EVH) guidance history: what it guided and what it reported
Evolent Health gave guidance in 3 earnings releases on file since May 7, 2026. Its releases raised guidance twice and lowered it 0 times.
Revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $2.4B–$2.6B (May 7, 2026) → raised $2.6B–$2.7B (Aug 6, 2026) → reaffirmed $2.6B–$2.7B (Nov 5, 2026) | — | to be reported | — |
Adjusted EBITDA
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2027 | $150M (Aug 6, 2026) | — | to be reported | — |
| FY2026 | $110M–$140M (May 7, 2026) → raised $120M–$135M (Aug 6, 2026) → raised $130M–$135M (Nov 5, 2026) | — | to be reported | — |
The latest quarter
Evolent Health, Q3 2026: revenue $725M (+51% year over year), operating margin -0.9%, net loss $23.6M, operating cash flow $26.4M. The chart follows the revenue to costs, profit and cash.
Questions
Does Evolent Health beat its guidance?
Evolent Health gave guidance in 3 earnings releases on file since May 7, 2026. Its releases raised guidance twice and lowered it 0 times.
How often does Evolent Health raise guidance?
Its earnings releases raised guidance twice and lowered it 0 times since May 7, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.